ODYY Odyssey Health, Inc.
Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1626644 · Fiscal year ends 07/31
Financial factors as of 2026-07-31 (2026Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-228.8%
TTM EPS YoY-150.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-5,799.8%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets8,303.6%
Debt / equity—
Current ratio0.01x
Interest coverage-0.58x
Cash quality & payout
Operating cash flow / net income0.18x
Accruals ratio-4,740.6%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-07-31 | FY20252025-07-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| R&D expense | $0 | $22,625 |
| SG&A expense | $912,994 | $1.02M |
| Operating income | -$912,994 | -$1.02M |
| Interest expense | $1.58M | $252,516 |
| Income tax | $0 | $0 |
| Net income | -$5.73M | -$1.74M |
| EPS (basic) | -0.05 | -0.02 |
| EPS (diluted) | -0.05 | -0.02 |
| Weighted avg. shares (diluted) | 108.32M | 104.71M |
| Balance sheet | ||
| Cash & equivalents | $122,361 | $19,084 |
| Current assets | $147,859 | $49,723 |
| Total assets | $147,859 | $49,723 |
| Current liabilities | $12.28M | $7.00M |
| Total liabilities | $12.28M | $7.00M |
| Shareholders' equity | -$12.13M | -$6.95M |
| Shares outstanding | 105.97M | 96.71M |
| Cash flow statement | ||
| Operating cash flow | -$1.05M | -$347,392 |
| Investing cash flow | $0 | $69,787 |
| Financing cash flow | $1.15M | $294,310 |
| Stock-based compensation | $5,408 | $108,399 |
Free plan shows the latest 2 periods; Pro shows all 12 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.